Posted by Jack Haddad on February 26, 2008 at 11:58 am
Team,
On Feb the 22nd, I recommended IMCL as a buy due to its favorable clinical trial data on subjects with advanced lung cancer. At that time, I recommended the shares at 42 while writing the march strike 40 calls at 3.10 to 3.2 per contract. Those who bought today have the following choices:
A. Continue to […]
Filed Under Random and
Stock Insight and
Stock News and
Stock Trades and
Uncategorized |
Leave a comment!
----------------------------------------
Posted by Jack Haddad on February 22, 2008 at 1:40 pm
I direct your attention to ImClone, the sole producer of the blockbuster drug “Erbitux.”
Phase III clinical trials on subjects with advanced lung cancer has yielded efficaceous results. Therefore, the FDA is highly expected to approve the trial in its meeting this month. IN reviewing the trial’s data, I’m leaning toward the likelihood that the study will […]
Filed Under Random and
Stock Insight and
Stock News and
Stock Trades and
Uncategorized |
2 comments!
----------------------------------------
Posted by Jack Haddad on February 22, 2008 at 12:54 pm
Apple’s challenges regarding its inability to generate the promised sales and revenue from iphones is not warranted. because the iPhone likely generates gross margins of 55% to 60% — compared with 30% to 33% gross margins for the rest of Apple’s product line — the device could be responsible for as much as 80% of […]
Filed Under Random and
Stock Insight and
Stock News and
Stock Trades and
Uncategorized |
3 comments!
----------------------------------------
Posted by Jack Haddad on February 20, 2008 at 12:59 pm
Bought 2 blocks of CROX at 27.41, and hedged the shares with 200 March strike 28, at 1.80/contract. CROX shares are trading at 10.5x our 2008 EPS estimate, despite expected EPS growth of 33% in 2008 and 19% in 2009. Though Crocs’s inventories increased 188% year-over-year and accounts receivables increased 133%, it had sales growth of […]
Filed Under Random and
Stock Insight and
Stock Trades and
Uncategorized |
2 comments!
----------------------------------------
Posted by Jack Haddad on February 20, 2008 at 8:58 am
Team,
Just bought 2 blocks of GRMN at 63.70. Be advised that it’s currently in a conference call with analysts as it has reported a stellar quarter. Beside strong fundamentals, the technicals on the hourly chart looks very oversold– down from an intraday high of 73.29.
Garmin said that revenue for the fourth quarter nearly doubled to […]
Filed Under Random and
Stock Insight and
Stock News and
Stock Trades and
Uncategorized |
Leave a comment!
----------------------------------------
